| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $278.6M | +5.3% | +11.3% |
| Cost of Revenue | $21.6M | +4.4% | +14.8% |
| R&D Expense | $87.8M | +12.7% | +31.9% |
| SG&A Expense | $133.4M | -0.1% | +0.1% |
| Operating Income | $35.8M | +10.4% | +13.0% |
| Pre-tax Income | $44.6M | +10.9% | +14.9% |
| Income Tax | -$27.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $258.0M | +1.7% | +66.3% |
| Accounts Receivable | $115.8M | +7.8% | +18.0% |
| Inventory | $106.0M | -4.1% | +22.2% |
| Current Assets | $1.08B | +12.1% | +36.6% |
| Total Assets | $1.33B | +8.6% | +36.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $158.6M | — | — |
| Capital Expenditures | $685K | — | — |
| Investing Cash Flow | -$246.7M | — | — |
| Financing Cash Flow | $27.2M | — | — |
| Free Cash Flow | $157.9M | — | — |
| -300.7% |
| -550.0% |
| Net Income | $71.8M | +169.2% | +119.1% |
| EPS (Basic) | $0.43 | +168.8% | +115.0% |
| EPS (Diluted) | $0.42 | +162.5% | +110.0% |
| $356.6M |
| +8.0% |
| +3.7% |
| Total Liabilities | $413.5M | +2.6% | +3.5% |
| Stockholders' Equity | $917.3M | +11.5% | +58.9% |